- Visibility 606 Views
- Downloads 622 Downloads
- Permissions
- DOI 10.18231/j.agems.v.12.i.1.9
-
CrossMark
Integrating quantum resonance therapy (Celtron MMO + PEMF) with traditional physiotherapy in Parkinson’s disease: Clinical efficacy in alleviating motor and non-motor symptoms
- Author Details:
-
Mandar Murlidhar Dharmadhikari *
Mandar Murlidhar Dharmadhikari *
Background: Parkinson’s disease dementia (PDD) affects 30–80% of Parkinson’s patients within a decade of diagnosis, with limited treatment efficacy from conventional therapies. This study evaluates the novel integration of Quantum Resonance Therapy (QRT)—combining Celtron’s Magnetic Mechanic Oscillator (MMO; 8–12 Hz) and Pulsed Electromagnetic Field (PEMF; 10–30 Hz)—with traditional physiotherapy to address motor and non-motor symptoms in PDD through mechanobiological mechanisms.
Objective: To assess the clinical efficacy of QRT + physiotherapy in alleviating motor rigidity, gait dysfunction, cognitive decline, and caregiver burden, while elucidating underlying mechano-transduction and neuroplasticity pathways.
Materials and Methods: A prospective observational study (STROBE-compliant) was conducted on a 50+ year-old PDD patient (DSM-5-confirmed, MMSE ≤24). The 6-week intervention included:
QRT: MMO (20 min/session, prone) + PEMF (8–12 Hz, 10 mT) twice weekly.
Physiotherapy: Balance/strength training, dual-task exercises, and aerobic activity thrice weekly. Caregiver education: Two sessions on mobility/behaviour management. Outcomes were tracked using: Berg Balance Scale (BBS), Dynamic Gait Index (DGI), Mini-Mental State Exam (MMSE), Quality of Life in Dementia (QOL-D), and Zarit Burden Interview (ZBI).
Results: Significant improvements were observed post-intervention: Motor Function: BBS increased 140% (10 → 24/56; reduced fall risk), DGI improved 500% (1 → 6/24). These improvements exceed historical benchmarks from conventional physiotherapy-only interventions, which typically show 30-50% improvements in balance scores and 20-30% gains in gait measures in similar PDD populations.
Cognition: MMSE rose 22% (18 → 22/30). This cognitive improvement compares favorably to historical data showing 5-10% MMSE improvements with standard care alone in PDD patients.
Quality of Life: QOL-D increased 51% (45 → 68/100). Caregiver Burden: ZBI decreased 40% (42→25/88). Synergistic effects of QRT + physiotherapy outperformed conventional therapy benchmarks, correlating with enhanced cortical excitability (PEMF) and reduced fascial rigidity (MMO).
Conclusion: QRT + physiotherapy significantly improved motor-cognitive function and reduced caregiver burden in PDD, likely through mechano-biological (MMO-induced fascial remodeling) and neuroplastic (PEMF-mediated dopaminergic modulation) mechanisms. This cost-effective, non-invasive protocol warrants validation in larger randomized trials, with potential to redefine PDD rehabilitation paradigms.
References
- Dickson DW. Parkinson's disease and Parkinsonism: Neuropathology. Cold Spring Harb Perspect Med. 2012;2(8):a009621.
- Galvan A, Wichmann T. Pathophysiology of Parkinsonism. Mov Disord. 2008;23(2):183-96.
- Jansen KA, Donato DM, Balcioglu HE, Schmidt T, Danen EH, Koenderink GH. A guide to mechanobiology: Where biology and physics meet. Biochim Biophys Acta. 2015;1853(11 Pt B):3043-52.
- Muthane UB, Satishchandra P, Subhash MN. Parkinson's disease: Challenges in a developing country. Arch Neurol. 2004;61(12):1867-8.
- Sunghal B, Sinha S, Taly AB, Murthy P, Nagarathna R, Nagendra HR. Yoga therapy for Parkinson's disease: Preliminary findings. J Altern Comp Med. 2003;9(2):269-76.
- Ellis TD, de Goede CJ, Feldman RG, Wolters EC, Kwakkel G, Wagenaar RC. Efficacy of a physical therapy program in patients with Parkinson's disease: A randomized controlled trial. Arch Phys Med Rehabil. 2005;86(4):626-32.
- Oschman JL. Energy medicine: The scientific basis. Churchill Livingstone; 2016.
- Mohammad D, Wood M, Huang S. Mechanobiology tools for studying cellular responses to mechanical forces. Nat Methods. 2021;18(5):439-48.
- Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation. Arch Phys Med Rehabil. 2005;86(4):789-92.
- Shen X, Wong-Yu IS, Mak MK. Effects of exercise on falls, balance, and gait ability in Parkinson's disease: A meta-analysis. Neurorehabil Neural Repair. 2016;30(6):512-27.
- Schenkman M, Hall DA, Barón AE, Schwartz RS, Mettler P, Kohrt WM. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012;92(11):1395-410.
- Leroi I, Overshott R, Byrnes J, Daniel E, Burns A. Randomized controlled trial of memantine in dementia associated with Parkinson's disease. Mov Disord. 2009;24(8):1217-21.
- Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2009;8(7):613-8.